Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RALTEGRAVIR Cause Intentional product use issue? 84 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 84 reports of Intentional product use issue have been filed in association with RALTEGRAVIR (ISENTRESS). This represents 1.0% of all adverse event reports for RALTEGRAVIR.

84
Reports of Intentional product use issue with RALTEGRAVIR
1.0%
of all RALTEGRAVIR reports
67
Deaths
49
Hospitalizations

How Dangerous Is Intentional product use issue From RALTEGRAVIR?

Of the 84 reports, 67 (79.8%) resulted in death, 49 (58.3%) required hospitalization, and 2 (2.4%) were considered life-threatening.

Is Intentional product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RALTEGRAVIR. However, 84 reports have been filed with the FAERS database.

What Other Side Effects Does RALTEGRAVIR Cause?

Foetal exposure during pregnancy (1,033) Maternal exposure during pregnancy (726) Exposure during pregnancy (700) Drug interaction (552) Virologic failure (517) Depression (482) Death (431) Pathogen resistance (425) Drug resistance (388) No adverse event (339)

What Other Drugs Cause Intentional product use issue?

INFLIXIMAB (11,028) RITUXIMAB (9,602) INFLIXIMAB-DYYB (7,549) TOCILIZUMAB (5,078) METHOTREXATE (4,087) PREDNISONE (3,961) ABATACEPT (3,693) ADALIMUMAB (3,557) NIVOLUMAB (3,297) LEFLUNOMIDE (3,280)

Which RALTEGRAVIR Alternatives Have Lower Intentional product use issue Risk?

RALTEGRAVIR vs RALTITREXED RALTEGRAVIR vs RAMELTEON RALTEGRAVIR vs RAMIPRIL RALTEGRAVIR vs RAMUCIRUMAB RALTEGRAVIR vs RANEXA

Related Pages

RALTEGRAVIR Full Profile All Intentional product use issue Reports All Drugs Causing Intentional product use issue RALTEGRAVIR Demographics